Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging
暂无分享,去创建一个
S. Canevari | O. Boerman | R. Valdagni | D. Mezzanzanica | E. Seregni | G. Franssen | G. Fracasso | M. Colombatti | M. Figini | B. Frigerio | A. Satta | E. Luison